Skip to main content
. 2003 Nov 3;1:Doc07.

Table 9. Base-case analysis: absolute and incremental discounted costs and efficacy, discounted incremental cost-effectiveness-ratio and discounted incremental cost-utility-ratio for different treatment strategies at annual 3% discount rate*.

Table 9